UNDISCLOSED(2022.11)
🩸 LIKELY CASUALTIES (AI ESTIMATE):
- 🔴Discovery & Early-Stage Research (non-CAR-T) (90%) ─ Reason: Unprofitable research streams, re-prioritized R&D.
- 🔴Clinical Development (non-CAR-T projects) (80%) ─ Reason: De-prioritized trial pipeline, asset divestment.
- 🟡R&D Project Management (70%) ─ Reason: Redundant project oversight, streamlined portfolio.
🤡 CORPORATE BS LEVEL:
85%













